Xuefen Le Bourhis

5.3k total citations
88 papers, 4.2k citations indexed

About

Xuefen Le Bourhis is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xuefen Le Bourhis has authored 88 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Molecular Biology, 23 papers in Cancer Research and 21 papers in Oncology. Recurrent topics in Xuefen Le Bourhis's work include Nerve injury and regeneration (14 papers), Glycosylation and Glycoproteins Research (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Xuefen Le Bourhis is often cited by papers focused on Nerve injury and regeneration (14 papers), Glycosylation and Glycoproteins Research (12 papers) and Cancer, Hypoxia, and Metabolism (11 papers). Xuefen Le Bourhis collaborates with scholars based in France, United States and Australia. Xuefen Le Bourhis's co-authors include Éric Adriaenssens, Hubert Hondermarck, Robert‐Alain Toillon, B. Boilly, Chann Lagadec, Valérie Chopin, Victor Nurcombe, Anne‐Sophie Vercoutter‐Edouart, Philippe Delannoy and Sylvain Julien and has published in prestigious journals such as Journal of Biological Chemistry, Bioinformatics and PLoS ONE.

In The Last Decade

Xuefen Le Bourhis

86 papers receiving 4.1k citations

Peers

Xuefen Le Bourhis
Guido Lenz Brazil
Timothy C. Burn United States
Suzie Chen United States
Huijun Wei United States
James Sinnett‐Smith United States
Fei Chen China
Guido Lenz Brazil
Xuefen Le Bourhis
Citations per year, relative to Xuefen Le Bourhis Xuefen Le Bourhis (= 1×) peers Guido Lenz

Countries citing papers authored by Xuefen Le Bourhis

Since Specialization
Citations

This map shows the geographic impact of Xuefen Le Bourhis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuefen Le Bourhis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuefen Le Bourhis more than expected).

Fields of papers citing papers by Xuefen Le Bourhis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuefen Le Bourhis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuefen Le Bourhis. The network helps show where Xuefen Le Bourhis may publish in the future.

Co-authorship network of co-authors of Xuefen Le Bourhis

This figure shows the co-authorship network connecting the top 25 collaborators of Xuefen Le Bourhis. A scholar is included among the top collaborators of Xuefen Le Bourhis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuefen Le Bourhis. Xuefen Le Bourhis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Völkel, Pamela, et al.. (2025). Ezh2 Loss-of-Function Alters Zebrafish Cerebellum Development. International Journal of Molecular Sciences. 26(19). 9736–9736.
2.
Fontaine, Emeline, Éric Adriaenssens, Robert‐Alain Toillon, et al.. (2025). Spatial self-organization of cancer stem cell niches revealed by live single-cell imaging. Stem Cell Research & Therapy. 16(1). 580–580.
3.
Chevalier, Dominique, et al.. (2023). Influence of EGF and pro-NGF on EGFR/SORTILIN interaction and clinical impact in head and neck squamous cell carcinoma. Frontiers in Oncology. 13. 661775–661775. 2 indexed citations
4.
Völkel, Pamela, et al.. (2023). The Contribution of the Zebrafish Model to the Understanding of Polycomb Repression in Vertebrates. International Journal of Molecular Sciences. 24(3). 2322–2322. 4 indexed citations
5.
Guette, Catherine, Hubert Hondermarck, Roland P. Bourette, et al.. (2023). Mitochondrial adaptation decreases drug sensitivity of persistent triple negative breast cancer cells surviving combinatory and sequential chemotherapy. Neoplasia. 46. 100949–100949. 5 indexed citations
6.
Vincent, Audrey, et al.. (2023). ABSP: an automated R tool to efficiently analyze region-specific CpG methylation from bisulfite sequencing PCR. Bioinformatics. 39(1). 3 indexed citations
7.
Bal-Mahieu, Christine, Ángel M. Carcaboso, Xuefen Le Bourhis, et al.. (2021). Evofosfamide Is Effective against Pediatric Aggressive Glioma Cell Lines in Hypoxic Conditions and Potentiates the Effect of Cytotoxic Chemotherapy and Ionizing Radiations. Cancers. 13(8). 1804–1804. 6 indexed citations
8.
Tian, Lü, Marie‐José Truong, Chann Lagadec, et al.. (2019). s-SHIP Promoter Expression Identifies Mouse Mammary Cancer Stem Cells. Stem Cell Reports. 13(1). 10–20. 6 indexed citations
9.
Völkel, Pamela, et al.. (2018). Combining genotypic and phenotypic analyses on single mutant zebrafish larvae. MethodsX. 5. 244–256. 10 indexed citations
10.
Chopin, Valérie, Chann Lagadec, Robert‐Alain Toillon, & Xuefen Le Bourhis. (2016). Neurotrophin signaling in cancer stem cells. Cellular and Molecular Life Sciences. 73(9). 1859–1870. 56 indexed citations
11.
Vennin, Constance, Nathalie Spruyt, Y Robin, et al.. (2016). The long non-coding RNA 91H increases aggressive phenotype of breast cancer cells and up-regulates H19/IGF2 expression through epigenetic modifications. Cancer Letters. 385. 198–206. 59 indexed citations
12.
Cazet, Aurélie, Marie Bobowski, Yoann Rombouts, et al.. (2012). The ganglioside GD2 induces the constitutive activation of c-Met in MDA-MB-231 breast cancer cells expressing the GD3 synthase. Glycobiology. 22(6). 806–816. 80 indexed citations
13.
Vanhecke, Elsa, Éric Adriaenssens, Stéphanie Verbeke, et al.. (2011). Brain-Derived Neurotrophic Factor and Neurotrophin-4/5 Are Expressed in Breast Cancer and Can Be Targeted to Inhibit Tumor Cell Survival. Clinical Cancer Research. 17(7). 1741–1752. 101 indexed citations
14.
Steenackers, Agata, Aurélie Cazet, Marie Bobowski, et al.. (2011). Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells. Comptes Rendus Chimie. 15(1). 3–14. 6 indexed citations
15.
Bourhis, Xuefen Le, Rodrigue Romon, & Hubert Hondermarck. (2009). Role of endothelial progenitor cells in breast cancer angiogenesis: from fundamental research to clinical ramifications. Breast Cancer Research and Treatment. 120(1). 17–24. 28 indexed citations
16.
Adriaenssens, Éric, Elsa Vanhecke, Pasquine Saule, et al.. (2008). Nerve Growth Factor Is a Potential Therapeutic Target in Breast Cancer. Cancer Research. 68(2). 346–351. 160 indexed citations
17.
Chopin, Valérie, Christian Slomianny, Hubert Hondermarck, & Xuefen Le Bourhis. (2004). Synergistic induction of apoptosis in breast cancer cells by cotreatment with butyrate and TNF-alpha, TRAIL, or anti-Fas agonist antibody involves enhancement of death receptors' signaling and requires P21waf1. Experimental Cell Research. 298(2). 560–573. 76 indexed citations
18.
Chopin, Valérie, Robert‐Alain Toillon, Nathalie Jouy, & Xuefen Le Bourhis. (2004). P21WAF1/CIP1 is dispensable for G1 arrest, but indispensable for apoptosis induced by sodium butyrate in MCF-7 breast cancer cells. Oncogene. 23(1). 21–29. 84 indexed citations
19.
Dollé, Laurent, Éric Adriaenssens, Ikram El Yazidi‐Belkoura, et al.. (2004). Nerve Growth Factor Receptors and Signaling in Breast Cancer. Current Cancer Drug Targets. 4(6). 463–470. 81 indexed citations
20.
Toillon, Robert‐Alain, Simon Descamps, Éric Adriaenssens, et al.. (2002). Normal Breast Epithelial Cells Induce Apoptosis of Breast Cancer Cells via Fas Signaling. Experimental Cell Research. 275(1). 31–43. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026